These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7001957)

  • 1. [Suppression of transplantation immunity under the action of hyperbaric oxygenation].
    Bokeriia LA; Kostava VT; Khurges ISh; Frolova MA
    Anesteziol Reanimatol; 1980; (5):67-9. PubMed ID: 7001957
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of using hyperbaric oxygenation as an immunodepressant agent in total keratoplasty in an experiment].
    Laskarzhevskiĭ IuN
    Oftalmol Zh; 1987; (7):406-8. PubMed ID: 3327019
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusions of syngeneic blood do not seem to induce suppressive effect on antitumor or transplantation immunity in mice.
    Jakóbisiak M; Włodarski K; Lasek W; Górecki D; Płodziszewska M
    Arch Immunol Ther Exp (Warsz); 1985; 33(4):543-7. PubMed ID: 3909991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z; Cobbold S; Waldmann H; Metcalfe S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothermic-hyperbaric pulsatile perfusion for preservation of the canine heart.
    Feemster JA; Lillehei RC
    Transplant Proc; 1969 Mar; 1(1):138-46. PubMed ID: 4944210
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal induction of tolerance to cardiac allografts.
    West LJ; Morris PJ; Wood KJ
    Transplant Proc; 1994 Feb; 26(1):207-8. PubMed ID: 8108945
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive and cardiotoxic effects of cyclosporine in CBA mice.
    Mottram PL; Mirisklavas A; Mason A; Dumble LJ; Smith JA; Clunie GJ; Panagiotopoulos S; Nayler WG
    Transplantation; 1989 Oct; 48(4):720-3. PubMed ID: 2799937
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
    J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterotopic transplantation of the heart in animals with induced immunological tolerance].
    Frolova MA; Kokorin IN; Fontalin LN; Fal'kovskiĭ GE
    Eksp Khir Anesteziol; 1973; (1):22-8. PubMed ID: 4618799
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts.
    Campos L; Deli BC; Kern JH; Kim JI; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1995 Feb; 27(1):254-5. PubMed ID: 7878991
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody.
    Aramaki O; Shirasugi N; Akiyama Y; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Niimi M
    Transplantation; 2003 Nov; 76(9):1305-14. PubMed ID: 14627908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunodepressive action of anthracycline antibiotics studied on 2 different transplantation immunity models].
    Liashenko VA; Shapovalova SP; Aleksander SK
    Antibiotiki; 1981 Jul; 26(7):546-9. PubMed ID: 7023378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression.
    Saitovitch D; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):119-20. PubMed ID: 7878844
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
    Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model.
    Han WR; Mottram PL; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2933-4. PubMed ID: 8105591
    [No Abstract]   [Full Text] [Related]  

  • 16. Insights into the mechanism of allograft acceptance in T-cell receptor (beta-chain) transgenic mice.
    Barrett LV; Rimm IJ; Wiens GR; Seidman JG; Kirkman RL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):366-7. PubMed ID: 8438338
    [No Abstract]   [Full Text] [Related]  

  • 17. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4+ regulatory cells.
    Yokoyama T; Aramaki O; Takayama T; Takano S; Zhang Q; Shimazu M; Kitajima M; Ikeda Y; Shirasugi N; Niimi M
    J Thorac Cardiovasc Surg; 2005 Oct; 130(4):1167-74. PubMed ID: 16214535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloned veto cells as immunoregulators.
    Takeda Y; Yanagie H; Maki T
    Transplant Proc; 1993 Aug; 25(4):2743-4. PubMed ID: 8356732
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
    Chen Z; Cobbold SP; Waldmann H; Metcalfe SM
    Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.